Literature DB >> 22331764

Tumor-initiating label-retaining cancer cells in human gastrointestinal cancers undergo asymmetric cell division.

Hong-Wu Xin1, Danielle M Hari, John E Mullinax, Chenwi M Ambe, Tomotake Koizumi, Satyajit Ray, Andrew J Anderson, Gordon W Wiegand, Susan H Garfield, Snorri S Thorgeirsson, Itzhak Avital.   

Abstract

Label-retaining cells (LRCs) have been proposed to represent adult tissue stem cells. LRCs are hypothesized to result from either slow cycling or asymmetric cell division (ACD). However, the stem cell nature and whether LRC undergo ACD remain controversial. Here, we demonstrate label-retaining cancer cells (LRCCs) in several gastrointestinal (GI) cancers including fresh surgical specimens. Using a novel method for isolation of live LRCC, we demonstrate that a subpopulation of LRCC is actively dividing and exhibits stem cells and pluripotency gene expression profiles. Using real-time confocal microscopic cinematography, we show live LRCC undergoing asymmetric nonrandom chromosomal cosegregation LRC division. Importantly, LRCCs have greater tumor-initiating capacity than non-LRCCs. Based on our data and that cancers develop in tissues that harbor normal-LRC, we propose that LRCC might represent a novel population of GI stem-like cancer cells. LRCC may provide novel mechanistic insights into the biology of cancer and regenerative medicine and present novel targets for cancer treatment.
Copyright © 2012 AlphaMed Press.

Entities:  

Mesh:

Year:  2012        PMID: 22331764      PMCID: PMC3492937          DOI: 10.1002/stem.1061

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  54 in total

1.  Mutation selection and the natural history of cancer.

Authors:  J Cairns
Journal:  Nature       Date:  1975-05-15       Impact factor: 49.962

Review 2.  Extrinsic regulation of pluripotent stem cells.

Authors:  Martin F Pera; Patrick P L Tam
Journal:  Nature       Date:  2010-06-10       Impact factor: 49.962

3.  Colonic stem cell data are consistent with the immortal model of stem cell division under non-random strand segregation.

Authors:  K Walters
Journal:  Cell Prolif       Date:  2009-03-27       Impact factor: 6.831

4.  Neutral endopeptidase inhibits prostate cancer cell migration by blocking focal adhesion kinase signaling.

Authors:  M Sumitomo; R Shen; M Walburg; J Dai; Y Geng; D Navarro; G Boileau; C N Papandreou; F G Giancotti; B Knudsen; D M Nanus
Journal:  J Clin Invest       Date:  2000-12       Impact factor: 14.808

5.  Immortal DNA strand cosegregation requires p53/IMPDH-dependent asymmetric self-renewal associated with adult stem cells.

Authors:  Lakshmi Rambhatla; Sumati Ram-Mohan; Jennifer J Cheng; James L Sherley
Journal:  Cancer Res       Date:  2005-04-15       Impact factor: 12.701

6.  Identification and characterization of tumorigenic liver cancer stem/progenitor cells.

Authors:  Stephanie Ma; Kwok-Wah Chan; Liang Hu; Terence Kin-Wah Lee; Jana Yim-Hung Wo; Irene Oi-Lin Ng; Bo-Jian Zheng; Xin-Yuan Guan
Journal:  Gastroenterology       Date:  2007-04-15       Impact factor: 22.682

7.  Reprogramming of human somatic cells to pluripotency with defined factors.

Authors:  In-Hyun Park; Rui Zhao; Jason A West; Akiko Yabuuchi; Hongguang Huo; Tan A Ince; Paul H Lerou; M William Lensch; George Q Daley
Journal:  Nature       Date:  2007-12-23       Impact factor: 49.962

8.  Differential expression of the CD10 antigen (neutral endopeptidase) in primary versus metastatic malignant melanomas of the skin.

Authors:  J Kanitakis; D Narvaez; A Claudy
Journal:  Melanoma Res       Date:  2002-06       Impact factor: 3.599

9.  Identification of pancreatic cancer stem cells.

Authors:  Chenwei Li; David G Heidt; Piero Dalerba; Charles F Burant; Lanjing Zhang; Volkan Adsay; Max Wicha; Michael F Clarke; Diane M Simeone
Journal:  Cancer Res       Date:  2007-02-01       Impact factor: 12.701

10.  Identification of stem cells in small intestine and colon by marker gene Lgr5.

Authors:  Nick Barker; Johan H van Es; Jeroen Kuipers; Pekka Kujala; Maaike van den Born; Miranda Cozijnsen; Andrea Haegebarth; Jeroen Korving; Harry Begthel; Peter J Peters; Hans Clevers
Journal:  Nature       Date:  2007-10-14       Impact factor: 49.962

View more
  27 in total

Review 1.  The role of epigenetic regulation in stem cell and cancer biology.

Authors:  Lilian E van Vlerken; Elaine M Hurt; Robert E Hollingsworth
Journal:  J Mol Med (Berl)       Date:  2012-06-02       Impact factor: 4.599

2.  Asymmetric chromatid segregation in cardiac progenitor cells is enhanced by Pim-1 kinase.

Authors:  Balaji Sundararaman; Daniele Avitabile; Mathias H Konstandin; Christopher T Cottage; Natalie Gude; Mark A Sussman
Journal:  Circ Res       Date:  2012-03-22       Impact factor: 17.367

3.  Sparse feature selection identifies H2A.Z as a novel, pattern-specific biomarker for asymmetrically self-renewing distributed stem cells.

Authors:  Yang Hoon Huh; Minsoo Noh; Frank R Burden; Jennifer C Chen; David A Winkler; James L Sherley
Journal:  Stem Cell Res       Date:  2015-01-06       Impact factor: 2.020

4.  Differential Sensitivities of Fast- and Slow-Cycling Cancer Cells to Inosine Monophosphate Dehydrogenase 2 Inhibition by Mycophenolic Acid.

Authors:  Kan Chen; Wanlu Cao; Juan Li; Dave Sprengers; Pratika Y Hernanda; Xiangdong Kong; Luc Jw van der Laan; Kwan Man; Jaap Kwekkeboom; Herold J Metselaar; Maikel P Peppelenbosch; Qiuwei Pan
Journal:  Mol Med       Date:  2015-10-13       Impact factor: 6.354

Review 5.  Strategies for isolating and enriching cancer stem cells: well begun is half done.

Authors:  Jiang-Jie Duan; Wen Qiu; Sen-Lin Xu; Bin Wang; Xian-Zong Ye; Yi-Fang Ping; Xia Zhang; Xiu-Wu Bian; Shi-Cang Yu
Journal:  Stem Cells Dev       Date:  2013-05-09       Impact factor: 3.272

6.  Label-retaining liver cancer cells are relatively resistant to sorafenib.

Authors:  Hong-Wu Xin; Chenwi M Ambe; Danielle M Hari; Gordon W Wiegand; Tyler C Miller; Jin-Qiu Chen; Andrew J Anderson; Satyajit Ray; John E Mullinax; Tomotake Koizumi; Russell C Langan; Douglas Burka; Michelle A Herrmann; Paul K Goldsmith; Alexander Stojadinovic; Udo Rudloff; Snorri S Thorgeirsson; Itzhak Avital
Journal:  Gut       Date:  2013-02-14       Impact factor: 23.059

7.  Expansion of cancer stem cell pool initiates lung cancer recurrence before angiogenesis.

Authors:  Lei Li; Jiang-Chao Li; Hong Yang; Xu Zhang; Lu-Lu Liu; Yan Li; Ting-Ting Zeng; Ying-Hui Zhu; Xiao-Dong Li; Yan Li; Dan Xie; Li Fu; Xin-Yuan Guan
Journal:  Proc Natl Acad Sci U S A       Date:  2018-08-29       Impact factor: 11.205

8.  Target Deconvolution of a Multikinase Inhibitor with Antimetastatic Properties Identifies TAOK3 as a Key Contributor to a Cancer Stem Cell-Like Phenotype.

Authors:  Yansong Bian; Yaroslav Teper; Lesley A Mathews Griner; Taylor J Aiken; Vivek Shukla; Rajarshi Guha; Paul Shinn; Hong-Wu Xin; Holger Pflicke; Astin S Powers; Dandan Li; Jian-Kang Jiang; Paresma Patel; Steven A Rogers; Jeffrey Aubé; Marc Ferrer; Craig J Thomas; Udo Rudloff
Journal:  Mol Cancer Ther       Date:  2019-08-08       Impact factor: 6.261

9.  Treatment of Triple-Negative Breast Cancer with TORC1/2 Inhibitors Sustains a Drug-Resistant and Notch-Dependent Cancer Stem Cell Population.

Authors:  Neil E Bhola; Valerie M Jansen; James P Koch; Hua Li; Luigi Formisano; Janice A Williams; Jennifer R Grandis; Carlos L Arteaga
Journal:  Cancer Res       Date:  2015-12-16       Impact factor: 12.701

10.  Higher 5-hydroxymethylcytosine identifies immortal DNA strand chromosomes in asymmetrically self-renewing distributed stem cells.

Authors:  Yang Hoon Huh; Justin Cohen; James L Sherley
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-30       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.